Kymera Therapeutics, Inc. KYMR
127.09 USD -0.42 (-0.33%)
At closeNov 3, 2026, 4:00 PM EST
128.17 +1.08 +0.85%
After hours · Nov 3, 4:00 PM ET
126.49 Day range 133.88
55.66 52-week range 133.88
- YTD
- +63.33%
- 1 year
- +112.81%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 144.39 +13.6% upside
Now 127.09
- Target (low)
- 112.00
- Target (mean)
- 144.39
- Target (high)
- 180.00
Ratings (0m) 24 22 buy · 2 hold · 0 sell
- Strong buy5
- Buy17
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 24
- 1 month ago 23
- 2 months ago 24
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.26 | -1.54 – -0.7767 | -0.98 | -28.4% | 76.92K | -97.3% | 20 |
| Next quarter | -1.32 | -1.52 – -1.01 | -0.71 | -86.2% | 8.40M | -75.6% | 6 |
| Current year | -3.88 | -4.21 – -3.13 | -3.69 | -5.2% | 99.41M | +153.5% | 21 |
| Next year | -5.04 | -6.70 – -3.36 | -3.88 | -29.9% | 42.03M | -57.7% | 21 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 30, 2026 | Truist Securities | Reiterated | Buy | Buy |
| Oct 30, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Oct 29, 2026 | BTIG | Maintained | Buy | Buy |
| Oct 27, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 9, 2026 | Raymond James | Initiated | — | Outperform |
| Oct 5, 2026 | Citigroup | Maintained | Buy | Buy |
| Sep 22, 2026 | Stifel | Maintained | Buy | Buy |
| Sep 14, 2026 | B of A Securities | Maintained | Buy | Buy |
| Sep 10, 2026 | Wolfe Research | Upgrade | Peer Perform | Outperform |
| Aug 31, 2026 | Guggenheim | Maintained | Buy | Buy |
| Aug 27, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Aug 6, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 30, 2026 | Deutsche Bank | Initiated | — | Hold |
| Jul 28, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 16, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jul 13, 2026 | RBC Capital | Downgrade | Outperform | Sector Perform |
| Jun 30, 2026 | B of A Securities | Maintained | Buy | Buy |
| Jun 29, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jun 29, 2026 | B. Riley Securities | Maintained | Buy | Buy |
| Jun 26, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Jun 25, 2026 | BTIG | Reiterated | Buy | Buy |
| May 6, 2026 | Canaccord Genuity | Initiated | — | Buy |
| Mar 3, 2026 | UBS | Maintained | Buy | Buy |
| Mar 2, 2026 | Citigroup | Maintained | Buy | Buy |
| Mar 2, 2026 | Stephens & Co. | Maintained | Overweight | Overweight |
| Feb 26, 2026 | BTIG | Maintained | Buy | Buy |
| Feb 26, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Feb 3, 2026 | BTIG | Reiterated | Buy | Buy |
| Jan 28, 2026 | Barclays | Maintained | Overweight | Overweight |